chr19-10567339-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001800.4(CDKN2D):c.220G>A(p.Gly74Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000551 in 1,614,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001800.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKN2D | NM_001800.4 | c.220G>A | p.Gly74Ser | missense_variant | 2/2 | ENST00000393599.3 | NP_001791.1 | |
CDKN2D | NM_079421.3 | c.220G>A | p.Gly74Ser | missense_variant | 3/3 | NP_524145.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKN2D | ENST00000393599.3 | c.220G>A | p.Gly74Ser | missense_variant | 2/2 | 1 | NM_001800.4 | ENSP00000377224.1 | ||
CDKN2D | ENST00000335766.2 | c.220G>A | p.Gly74Ser | missense_variant | 3/3 | 1 | ENSP00000337056.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152134Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251328Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135832
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.0000633 AC XY: 46AN XY: 727236
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152134Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.220G>A (p.G74S) alteration is located in exon 2 (coding exon 2) of the CDKN2D gene. This alteration results from a G to A substitution at nucleotide position 220, causing the glycine (G) at amino acid position 74 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at